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We have prepared and studied iron-oxide nanoparticles coated with oleic acid sOAd and Pluronic®
polymer. The mean diameter of the iron-oxide nanoparticles was 9.3s±d0.8 nm. Saturation
magnetization values measured at 10 K varied from 66.1s±0.7d emu/g to 98.7s±0.5d emu/g. At
300 K the loops showed negligible coercive field. The peaks in zero-field-cooled susceptibility
decreased from 280 to 168 K with increasing OA concentration up to 10.6 wt %, and remained
nearly constant for higher concentrations. This suggests that incomplete coverage of the
OA allows small, interacting agglomerates to form. © 2005 American Institute of Physics.
fDOI: 10.1063/1.1850855g
I. INTRODUCTION
The use of nanoparticles for drug delivery is a topic of
vigorous investigation. One approach is to package the drug
in a polymer-coated magnetic nanoparticle and use an exter-
nal magnetic field to target the nanoparticle. The challenges
are to develop a biocompatible material that has a long cir-
culation time, can be loaded with the drug, and has a large
enough moment for magnetic targeting.
Pluronic® block co-polymers can make phagocyte-
resistant nanoparticles with long blood-circulation time.1
Pluronic® is a water-soluble tri-block copolymer composed
of a hydrophobic central segment of polyspropylene oxided
flanked by two hydrophilic segments of polysethylene ox-
ided. Pluronic® can be represented as EOa -POb -EOa, where
a and b are the number of ethylene oxide and propylene
oxide units, respectively.2
Iron oxides are the most-studied materials for magnetic
targeting because of their favorable magnetic properties
and high biocompatibility. Both are ferrimagnetic with
magnetic transitions above 800 K.3 Bulk magnetite and
maghemite have the highest saturation magnetizations
sMSd among the iron oxides s92–100 emu/g and
60–80 emu/g, respectivelyd.3
Oleic acid sOAd is used for steric stabilization in nonpo-
lar solutions; however, OA has a low hydrophilic-lipophilic
balance sHLBd value of 1, making stabilization in water
difficult.4 Adding Pluronic® block copolymer, which has a
HLB value of 22, as a second layer enhances the dispersion
stability.
II. SAMPLE PREPARATION AND MEASUREMENT
Solutions of 0.1 M FesIIId and 0.1 M FesIId in water
were mixed with 5 M NH3 solution and the mixture was
stirred for 20 min in a N2 atmosphere. After stirring, OA was
added and the solution was heated to <353 K for 30 min
while stirring. Pluronic® F-127 was added after the solution
cooled to room temperature. Iron-oxide nanoparticles were
recovered by ultracentrifugation, washed twice with deion-
ized sDId water and re-dispersed in DI water by sonication.
The relative concentrations sin wt %d of iron-oxide, OA and
Pluronic® were varied: 0,Pluronic®,60, 0,OA,21.9,
and 36.5, iron-oxide,100. Lyophilized powder samples
were enclosed in polyethylene bags containing paraffin wax
to prevent the particles from rotating in the measuring field.
III. DISCUSSION
Figure 1 shows a typical x-ray diffraction sXRDd
powder-diffraction pattern. The similarity of maghemite and
magnetite XRD patterns makes it difficult to exclude the
formation of maghemite in the samples; however, the value
of the saturation magnetization suggests that magnetite com-
prises a significant fraction of the sample. The iron-oxide
nanoparticle diameter for all samples was 9.3±0.8 nm ssee
inset in Fig. 1d as obtained by an integral breadth analysis of
the XRD peaks. This result is in agreement with the mean
diameter of 8.9 nm from transmission electron microscopy
sTEMd. Figure 2 shows a representative TEM micrograph
and histogram of the size distribution.
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MsHd loops were normalized to the magnetite mass as
determined by atomic absorption spectroscopy sAASd. The
saturation magnetization sMSd, remanence ratio ss=Mr /MSd,
and coercive field sHcd were determined by fitting the mag-
netization curve with an analytical model5 plus a diamag-
netic background contribution.
Figure 3 shows MsHd at 10 and 300 K in a sample with
37.4 wt % of iron-oxide nanoparticles, 40.8 wt % Pluronic®,
and 21.8 wt % OA. As a function of OA content, MS at 10 K
increases from 66.1s±0.7d emug to 98.7s±0.5d emu/g re-
gardless of the relative concentration of iron oxide and Plu-
ronic®, and s varies from 0.21s±0.01d to 0.31s±0.01d. At
300 K the loops show negligible coercive field, and the mag-
netization at 1.2 T safter the diamagnetic background contri-
bution is removedd, ranged from 34.6s60.8d emu/g
to 61.2s±0.8d emu/g. MsHd loops measured at 300 K were
fit to a Langevin function weighted by a log-normal dis-
tribution of particle sizes, producing a mean particle size
comparable to that obtained by XRD and TEM.
The sample without any Pluronic® or OA had a MS of
66.1s±0.7d emu/g, which is comparable to that reported for
10 nm magnetite nanoparticles.6 The MS values at high OA
concentrations are larger than those expected for bulk
maghemite. The smaller MS values relative to bulk magnetite
could be due to an increase in the surface anisotropy induced
by chemisorption of OA.7,8
The inset of Fig. 3 shows the field-cooled and zero-field-
cooled susceptibilities, xZFCsTd and xFCsTd. The measure-
ment was made at a field of 100 Oe. Tmax, the position of the
peak, was determined from the zero of dxZFCsTd /dT. Tmax vs
OA concentration is shown in Fig. 4, where the leftmost two
points sat 0 wt % OAd correspond to uncoated and
Pluronic®-coated iron-oxide nanoparticles. The particles
covered with only Pluronic® have a similar Tmax as the un-
coated particles but a significantly higher MS of
75.8s±0.5d emu/g. We attribute this to the effect of Plu-
ronic® preventing the nanoparticles from oxidizing and/or
agglomerating.
The blocking temperature TB is defined as TB=KV /25k,
where V is the volume of the nanoparticles, K is the magnetic
anisotropy constant swhich ranges from 1.43104 to 5
3104 J /m3 for magnetite3,9d, and k is the Boltzmann con-
stant. Tmax will be equal to TB only in systems with negli-
gible inter-particle magnetic interaction. XRD and TEM
measurements show that the iron-oxide size is roughly con-
stant for all samples. If the particles were noninteracting and
superparamagnetic, Tmax should be similarly constant; how-
ever, Tmax varies from a maximum value of 280s65d K
to 168s±5d K as the OA concentration increases. The Tmax
observed at low OA concentration could be due to incom-
FIG. 1. XRD measurements of OA- and Pluronic®-coated iron-oxide nano-
particle powders. The inset shows the iron-oxide nanoparticle diameters
obtained from XRD measurements as a function of iron-oxide
concentration.
FIG. 2. A representative TEM micrograph and size distribution.
FIG. 3. The magnetization as a function of field for a sample with
37.4 wt % of iron-oxide nanoparticles, 40.8 wt % Pluronic®, and 21.8 wt %
OA, measured at 10 K ssolid lined and 300 K scirclesd. The inset shows the
FC and ZFC susceptibilities.
FIG. 4. Tmax vs OA concentration in wt %.
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plete coverage of the iron-oxide nanoparticles by the sur-
factant, allowing some nanoparticles to aggregate.
Using K=1.43104 J /m3 sfor magnetited yields a block-
ing temperature of 168 K, which would require a mean
nanoparticle diameter of about 20 nm. This is twice the size
obtained from XRD, TEM, and magnetization measure-
ments. Furthermore, the ratio Mr /Ms is smaller than the
value of 0.5 expected for noninteracting, randomly oriented
single-domain particles.10
The most likely explanation of the observed phenomena
is that one or more layers of Pluronic® surround a small
group of OA-coated iron-oxide nanoparticles. Inside the ag-
gregate, the nanoparticles are separated by the OA layers,
and this distance decreases interactions and determines the
value of Tmax. The higher value of Tmax could be due to
dipolar magnetic interactions among the iron-oxide nanopar-
ticles. These interactions slow the magnetic relaxation and
increase Tmax, as has been observed experimentally,9,11 and
theoretically.12 Tmax increases at low OA concentrations, in-
dicating that the iron-oxide nanoparticles are closer to each
other, which is consistent with incomplete covering by the
OA.
The process of magnetically targeted drug delivery in-
volves binding a drug to biocompatible magnetic nanopar-
ticles. Paclitaxel is a potent anti-neoplastic drug, but its high
hydrophobicity makes it difficult to develop into an effective
drug delivery system.13 Drug-loaded nanoparticles with OA
and Pluronic® F-127 showed good dispersibility in aqueous
media. A 5.4 wt % of paclitaxel could be incorporated into
the nanoparticles, which allowed sustained release over ten
days under in vitro conditions.
IV. CONCLUSIONS
We have synthesized iron-oxide nanoparticles coated
with oleic acid and Pluronic® tri-block polymer. Magnetic
measurements suggest that OA-coated iron-oxide nanopar-
ticles tend to aggregate. Pluronic® decreases aggregation,
improves the stability of the suspension in water and in-
creases blood circulation time. The combination of magnetic
properties, the ability to incorporate acceptable amounts of
drug into the particles, and the stability of the particles in
aqueous suspension suggest that these materials are ideal
candidates for magnetically targeted drug delivery.
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